CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62,424,293 | -32.5% | 1,734,972 | -16.4% | 1.41% | -24.7% |
| Q4 2022 | $92,482,750 | +58.6% | 2,075,000 | 0.0% | 1.88% | +50.8% |
| Q3 2022 | $58,328,000 | +4.3% | 2,075,000 | 0.0% | 1.24% | -16.6% |
| Q2 2022 | $55,942,000 | -20.8% | 2,075,000 | 0.0% | 1.49% | -3.2% |
| Q1 2022 | $70,675,000 | +1.3% | 2,075,000 | +15.0% | 1.54% | +25.4% |
| Q4 2021 | $69,737,000 | -19.3% | 1,804,795 | +12.8% | 1.23% | +2.8% |
| Q3 2021 | $86,384,000 | +1549.8% | 1,600,000 | +353.2% | 1.20% | +1146.9% |
| Q3 2020 | $5,236,000 | -65.0% | 353,072 | -69.3% | 0.10% | -67.0% |
| Q2 2020 | $14,950,000 | – | 1,150,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,132,259 | $30,526,000 | 7.80% |
| Ghost Tree Capital, LLC | 400,000 | $10,784,000 | 5.62% |
| Octagon Capital Advisors LP | 761,398 | $20,527,000 | 5.48% |
| VR Adviser, LLC | 865,116 | $23,324,000 | 4.59% |
| ACUTA CAPITAL PARTNERS, LLC | 267,195 | $7,204,000 | 4.01% |
| COMMODORE CAPITAL LP | 538,812 | $14,526,000 | 3.07% |
| Ikarian Capital, LLC | 616,700 | $16,628,000 | 3.03% |
| TSP Capital Management Group, LLC | 266,545 | $7,186,000 | 2.83% |
| Ikarian Capital, LLC | 537,958 | $14,504,000 | 2.64% |
| Ikarian Capital, LLC | 506,500 | $13,656,000 | 2.49% |